433940-00-2

Upstream product

• 433939-99-2 Ph(3-Cl)(5-OCHF₂)-(R)CH(OH)C(O)-Aze-Pab(2,6-diF)(Teoc) 
• 593-56-6 N-methoxylamine hydrochloride 

Downstream Products

• 433938-32-0 Ph(3-Cl)(5-OCHF₂)-(R)CH(OH)C(O)-Aze-Pab(2,6-diF)(OMe) 
• 433938-32-0 Ph(3-Cl)(5-OCHF₂)-(R)CH(OH)C(O)-(S)-Aze-Pab(2,6-diF)(OMe) 

Relevant academic research and scientific papers

PHARMACEUTICAL COMBINATION

There is provided a combination product comprising: (1) a compound of claim 1 in WO 02/44145 or a compound of claim 20 in WO 02/44145 (or derivative thereof)or a pharmaceutically-acceptable derivative thereof; and (1) a compound as defined in claim 1 of WO 01/28992 or (2) a compound of Claim 34 of WO 01/28992 or (3) Compound A or B or C or D (or pharmaceutically-acceptable salts thereof) for use in treating arrhythmia or a coagulation controlled complication thereof.